查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1620672

光採術產品市場：按產品、治療領域和最終用戶 - 2025-2030 年全球預測

Photopheresis Product Market by Product (Closed System, Open System), Therapeutic Area (Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年光採產品市值為5.1434億美元，預計到2024年將達到5.5219億美元，複合年成長率為7.83%，到2030年將達到8.7237億美元。

光採術是治療方法，主要用於治療皮膚 T 細胞淋巴瘤、移植物抗宿主疾病和一些自體免疫疾病等疾病。這些免疫相關疾病的日益普及、醫療技術的進步以及對個人化醫療的日益重視推動了光化學療法產品的全球市場。這種需求源於對與傳統治療方法相比副作用較少的替代療法的需要。它們的用途很廣泛，包括醫院、專科診所和門診手術中心，可以在其中發揮治療疾病和預防復發的作用。最終用戶主要包括專門從事腫瘤學和血液學的醫療保健提供者。影響市場的主要發展因素包括患者數量的增加、醫療保健支出的增加以及對醫療基礎設施快速發展的新興市場的日益關注。將人工智慧整合到光化學療法設備中等技術創新提供了顯著的機會。然而，市場成長受到高昂的設備成本、嚴格的監管要求以及缺乏對治療益處的廣泛認知的限制。此外，操作和管理如此複雜的設備需要熟練的專業人員，這在低度開發地區可能是一個限制因素。這項創新研究旨在提高光化學療法設備的功效和可負擔性，並探索潛在的新臨床適應症。與製藥公司和學術機構的策略研究合作可以加速產品開發。此外，增加有關光化學療法的推廣和教育可以幫助佔領更大的市場佔有率。該市場競爭激烈，其特點是不斷的技術創新，導致數位健康解決方案的整合度不斷提高，從而提高治療效果和患者的治療效果。

主要市場統計
基準年[2023] 51434萬美元
預計年份 [2024] 55219萬美元
預測年份 [2030] 8.7237 億美元
複合年成長率（%） 7.83%

市場動態：快速發展的光採產品市場的關鍵市場洞察

供需的動態交互作用正在改變光採產品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 自體免疫疾病和癌症疾病的盛行率上升
    • 全球醫療保健支出不斷增加，人們對慢性病的認知不斷增強
  • 市場限制因素
    • 光採治療相關的高成本
  • 市場機會
    • 光化學療法產品的技術進步
    • 光採產品製造商與醫療機構之間的合併活動
  • 市場挑戰
    • 與光採術產品和治療相關的監管和報銷問題

波特的五力：駕馭光採產品市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解光採產品市場的外部影響

外部宏觀環境因素在塑造光採產品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解光採產品市場的競爭狀況

對光分離產品市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣光採產品市場廠商績效評估

FPNV定位矩陣是評估光採產品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃光採產品市場的成功之路

光採產品市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 自體免疫疾病和癌症的發生率上升
      • 全球醫療保健成本不斷上升，人們對慢性病的認知不斷增強
    • 抑制因素
      • 光採治療相關的高成本
    • 機會
      • 光化學療法產品的技術進步
      • 光採產品製造商與醫療機構之間的合併活動
    • 任務
      • 與光化學療法產品和治療相關的監管和報銷問題
  • 市場區隔分析
    • 產品：更多採用封閉式系統以提高病人安全
    • 最終用戶：醫院對提供綜合治療環境的光化學療法產品的需求不斷成長。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章光採產品市場：依產品

  • 封閉式系統
  • 開放系統

第7章光採術產品市場（依治療領域）

  • 自體免疫疾病
  • 皮膚T細胞淋巴瘤
  • 移植物抗宿主疾病
  • 固態器官移植排斥反應

第8章光採產品市場：依最終用戶分類

  • 門診中心
  • 醫院
  • 專科診所

第9章 北美、南美光採產品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太光採產品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲光採產品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 費森尤斯·卡比 (Fresenius Kabi) 為非親分離器引入單針功能
    • 日本核准Mallinckrodt 的 CELLEX 光分離系統用於慢性 GVHD 治療的保險報銷
  • 戰略分析和建議

公司名單

  • BioCardia, Inc.
  • Bristol-Myers Squibb Company
  • Fresenius SE & Co. KGaA
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Macopharma
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer Inc.
  • PIT Medical Systems GmbH
  • Sanofi SA
  • Terumo Corporation
  • Transimmune AG
Product Code: MRR-030EE4851624

The Photopheresis Product Market was valued at USD 514.34 million in 2023, expected to reach USD 552.19 million in 2024, and is projected to grow at a CAGR of 7.83%, to USD 872.37 million by 2030.

Photopheresis, a therapeutic procedure involving the extracorporeal treatment of blood with UV light and photosensitizing agents, is primarily used to treat conditions like cutaneous T-cell lymphoma, graft versus host disease, and some autoimmune disorders. The global market for photopheresis products is driven by the increasing prevalence of these immune-related disorders, advancements in medical technologies, and a growing emphasis on personalized medicine. Its necessity stems from the need for alternative treatments that offer fewer side effects compared to conventional therapies. The applications span across hospitals, specialty clinics, and ambulatory surgical centers, where it serves as a therapeutic and sometimes preventative measure against disease relapse. End-users mainly include healthcare providers specializing in oncology and hematology. Key growth factors influencing the market include a rising patient pool, increased healthcare spending, and stronger focus on emerging markets where healthcare infrastructure is rapidly developing. Technological innovations, like the integration of AI in photopheresis machines, present notable opportunities. However, market growth is limited by the high cost of devices, stringent regulatory requirements, and a lack of widespread awareness regarding the treatment's benefits. Moreover, skilled professionals are required to operate and manage these sophisticated devices, which can be a limiting factor in underdeveloped regions. Innovative research could target improving the efficacy and affordability of photopheresis equipment and exploring potential new clinical indications. Strategic collaborations with pharmaceutical firms and academic institutions could accelerate product development. Furthermore, increasing outreach and education about photopheresis could help in capturing a larger market share. The market is highly competitive and characterized by continuous innovation, with trends pointing towards a greater integration of digital health solutions to enhance treatment efficacy and patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 514.34 million
Estimated Year [2024] USD 552.19 million
Forecast Year [2030] USD 872.37 million
CAGR (%) 7.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Photopheresis Product Market

The Photopheresis Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of autoimmune and cancer diseases
    • Increased global healthcare spending and growing awareness about chronic diseases
  • Market Restraints
    • High costs associated with photopheresis treatments
  • Market Opportunities
    • Technological advancements in photopheresis products
    • Amalgamation activities between photopheresis product manufacturers and healthcare institutions
  • Market Challenges
    • Regulatory and reimbursement issues associated with photopheresis products and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Photopheresis Product Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Photopheresis Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Photopheresis Product Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Photopheresis Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Photopheresis Product Market

A detailed market share analysis in the Photopheresis Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Photopheresis Product Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Photopheresis Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Photopheresis Product Market

A strategic analysis of the Photopheresis Product Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Photopheresis Product Market, highlighting leading vendors and their innovative profiles. These include BioCardia, Inc., Bristol-Myers Squibb Company, Fresenius SE & Co. KGaA, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Macopharma, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., PIT Medical Systems GmbH, Sanofi S.A., Terumo Corporation, and Transimmune AG.

Market Segmentation & Coverage

This research report categorizes the Photopheresis Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Closed System and Open System.
  • Based on Therapeutic Area, market is studied across Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases, and Solid Organ Transplant Rejections.
  • Based on End User, market is studied across Ambulatory Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of autoimmune and cancer diseases
      • 5.1.1.2. Increased global healthcare spending and growing awareness about chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with photopheresis treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in photopheresis products
      • 5.1.3.2. Amalgamation activities between photopheresis product manufacturers and healthcare institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory and reimbursement issues associated with photopheresis products and treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing adoption of closed systems for increased patient safety
    • 5.2.2. End User: Higher need for photopheresis products in hospitals to offer a comprehensive treatment environment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Photopheresis Product Market, by Product

  • 6.1. Introduction
  • 6.2. Closed System
  • 6.3. Open System

7. Photopheresis Product Market, by Therapeutic Area

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cutaneous T-cell Lymphoma
  • 7.4. Graft Versus Host Diseases
  • 7.5. Solid Organ Transplant Rejections

8. Photopheresis Product Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Photopheresis Product Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Photopheresis Product Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Photopheresis Product Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Fresenius Kabi Introduces Single-Needle Function in Amicus Separator
    • 12.3.2. Japan Approves Reimbursement for Mallinckrodt's CELLEX Photopheresis System in Treating Chronic GVHD
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioCardia, Inc.
  • 2. Bristol-Myers Squibb Company
  • 3. Fresenius SE & Co. KGaA
  • 4. Johnson & Johnson Services, Inc.
  • 5. Koninklijke Philips N.V.
  • 6. Macopharma
  • 7. Mallinckrodt Pharmaceuticals
  • 8. Merck & Co., Inc.
  • 9. Pfizer Inc.
  • 10. PIT Medical Systems GmbH
  • 11. Sanofi S.A.
  • 12. Terumo Corporation
  • 13. Transimmune AG

LIST OF FIGURES

  • FIGURE 1. PHOTOPHERESIS PRODUCT MARKET RESEARCH PROCESS
  • FIGURE 2. PHOTOPHERESIS PRODUCT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHOTOPHERESIS PRODUCT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHOTOPHERESIS PRODUCT MARKET DYNAMICS
  • TABLE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CUTANEOUS T-CELL LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY GRAFT VERSUS HOST DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SOLID ORGAN TRANSPLANT REJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023